Skip to main content

Real-time Cardiorespiratory Status
to Improve Patient Care

Only the AGM100 provides non-invasive, reproducible measurements that detect cardiorespiratory impairment and streamline clinical decisions

Clinicians use AGM100 to:

  • Identify respiratory impairment at the point of care
  • Guide diagnosis and treatment decisions from chronic to acute cases
  • Assess treatment effectiveness
  • Identify change in a patient's cardiorespiratory status

 

AGM100 in Practice

The AGM100 is designed to identify hypoxemic patients like those with COPD or heart failure where the transfer of oxygen from the lungs to the blood is impaired. The Oxygen Deficit represents the degree of severity of gas exchange impairment and is more informative than PaO2 alone. 

Assessments can be performed by anyone on the medical team with minimal product training. The procedure takes 2 minutes while the patient breathes at rest while wearing a pulse oximeter. The results include oxygenation, ventilation, and pulmonary gas exchange information that is useful throughout the continuum of care for cardiorespiratory patients.

Relevant Medical Conditions

  • COPD
  • Heart Failure
  • Pneumonia
  • Pulmonary Embolism
  • Pulmonary Edema
  • Long COVID
  • Coronary Artery Disease
  • Interstitial Lung Disease
  • Acute Respiratory Distress Syndrome

ER and Inpatient Care

Fast, non-invasive assessment of a patient's cardiorespiratory status.

Surgery team working together in a surgical room

 

Improve Patient Care

Use with quick response team to help identify the chief problem

Monitor V/Q matching with Oxygen Deficit

Repeatable steady state analysis improves monitoring patients trending

Improve Operational Efficiency

Use Oxygen Deficit to help make home/observe/admission decisions

Use Oxygen Deficit to help predict the need for escalated care like supplemental oxygen

Identify hypoxic condition to improve treatment decisions

Differential Diagnosis and Condition Severity

Use Oxygen Deficit for differential diagnosis e.g., NSTEMI vs PE

Determine the severity of cardiorespiratory patients using Oxygen Deficit

Identify or narrow the cause of diffuse chief complaints like shortness of breath or chest pain

 

Reduce Post-Operative Risk

Guide monitoring for residual shunt from the intra-operative period

Help early identification of atelectasis leading to hypoxemia

Support identification of post-anesthesia hypoventilation

Improve Discharge Safety

Non-invasive confirmation of gas exchange efficiency before patient discharge

Help reduce avoidable postoperative pulmonary complications

Trend cardiorespiratory status in follow up visits

Outpatient Care

Assess patient arterial oxgygen, end tidal CO2 and end tidal O2 without leaving your office.

In-Use-with-Screen-Smaller-cropped

 

Assess Patients in Clinic

Reduce the number of patients sent to lab or ER for information like PaO2

Steady state analysis improves accuracy monitoring patients over time

Enhanced Cardiorespiratory Information

Blood oxygenation, ventilation, and gas exchange simultaneously

Determine cardiorespiratory impairment severity using Oxygen Deficit

Increase Operational Efficiency

2-minute test allows assistant to make the measurement before being seen by the clinician

Automatic steady state recognition for repeatable result to test treatment effectiveness

Latest Articles and Updates

MediPines Announces New Reimbursement Code for Non-Invasive Assessment of Cardiorespiratory Status by the AGM100

New AMA CPT® Code Establishes Pathway For Clinicians To Submit Claims For Use Of MediPines AGM100®
Sammy Lee

MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the "Make Your Medical Device Pitch for Kids!" competition presented by ...
Sammy Lee

UCSD Distinguished Lecture Series

UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza August 02, 2023 11:57 AM Eastern Daylight Time MediPines, ...
Andrew Mcfadden

Medscape Interview Highlights MediPines AGM100’s 99% Accuracy for Emergency Room Oxygen Therapy Decisions in COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology ...
Sammy Lee

Medipines Featured in Los Angeles Business Journal

Innovative Technology Detects Respiratory Impairment Respiratory impairment detection has long been a diagnostic “blind spot,” with the traditional tools available causing ...
Sammy Lee

Emergency Department Study Demonstrates Utility of MediPines AGM100 in Triaging COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a study presented at the American Thoracic Society (ATS) International Conference 2022, the MediPines AGM100 was shown to provide data that ...
Sammy Lee

Physicians Use MediPines Non-Invasive Gas-Exchange Analyzer Technology to Assist with Differential Diagnosis for Pulmonary Embolism

YORBA LINDA, Calif., May 24, 2022–(BUSINESS WIRE)–An increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and ...
Sammy Lee

MediPines Adds Three Global Thought Leaders to its Medical and Scientific Advisory Board

March 01, 2022 12:04 PM Eastern Standard Time YORBA LINDA, Calif.–(BUSINESS WIRE)–Orange County, California based MediPines Corporation, a market leader in the development of gas ...
Sammy Lee

World Health Organization Recognizes MediPines AGM100® in 2021 Compendium for Innovative Health Technologies

ORANGE COUNTY, Calif., Sept. 21, 2021 /CNW/ — The World Health Organization (WHO) has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology ...
Sammy Lee

Pulmonary Outpatient Clinics

Enhanced cardiorespiratory clinical information

Blood oxygenation, ventilation, and gas exchange simultaneously

Determine cardiorespiratory severity using O2 Deficit (non-invasive A-a gradient)

Establish clear baseline patient measurement prior to procedure

Increased operational efficiency

2-minute test allows MA to collect data and update chart before being seen by the MD

Automatic steady state recognition for repeatable result to test treatment effectiveness

Immediate results in office for faster clinical decisions

Assess patients in the clinic

Fully reimbursable procedure

Reduce the number of patients sent to lab or ER for similar information

Objective, repeatable test improves monitoring patients over time

 

Hospitals - Step Down, Critical Care, ER

Care path decisions and operational efficiency

Use O2 Deficit to make home/observe/admission decisions

Use O2 Deficit to predict the need for escalated care like supplemental oxygen

Identify hypoxic condition and sources of hypoxemia to direct treatment

Differential diagnosis and condition severity

Use O2 Deficit for differential diagnosis e.g., NSTEMI vs PE

Determine cardiorespiratory severity using O2 Deficit (non-invasive A-a gradient)

Add clarity in diffuse chief complaints like shortness of breath or chest pain

Relevant to Cardiology, Pulmonology, Respiratory

Used with quick response team to help identify the chief problem

Use O2 Deficit as a surrogate for V/Q matching

Objective, repeatable test improves monitoring patients over time

 

Surgical Procedures

Preoperative Gas Exchange Assessment

Risk stratify surgical patients for postoperative pulmonary complications

Preoperative evaluation to determine oxygenation strategies

Establish baseline measurement prior to anesthesia

 

Postoperative Gas Exchange Assessment

Monitor for residual shunt from the intra-operative period

Early identification of atelectasis leading to hypoxemia

Monitor for post-anesthesia hypoventilation

 

Improved Patient Discharge Safety

Confirm gas exchange efficiency before patient discharge

Reduce avoidable postoperative pulmonary complications

Confirm pharmacological effectiveness

 

Interventional Procedures

Before diagnostic cardiac catheterizations and imaging

Identify hypoxic condition and sources of hypoxemia to direct treatment

Complement ultrasound to determine severity using O2 Deficit (non-invasive A-a gradient)

Establish clear baseline patient measurement prior to procedure

During procedures aimed at improving V/Q matching

Confirm degree of the blockage being treated

Identify secondary blockages with changes in gas exchange

Maintain stable V/Q matching before ending the procedure

 

Post procedures and patient follow up

Confirm pharmacological effectiveness before patient discharge

Use oxygen deficit to approximate pulmonary vascular pressures

Manage fluid buildup (edema) in heart failure to avoid readmission